{"analyses":[{"ciLowerLimit":"-0.27","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"0.94","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","paramType":"Median Difference (Final Values)","paramValue":"0.26"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"6.11","value":"1.60"},{"groupId":"OG001","lowerLimit":"0","upperLimit":"5.84","value":"1.59"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"44"},{"groupId":"OG001","value":"46"}],"units":"Participants"}],"description":"Total amount of narcotic use in morphine equivalents will be divided by the total hours of inpatient hospitalization, multiplied by 24 hours, to obtain the daily narcotic consumption.","dispersionType":"Full Range","groups":[{"description":"Gabapentin liquid by mouth or per Tube 300mg twice a day","id":"OG000","title":"Gabapentin"},{"description":"Placebo liquid by mouth or Per Tube twice a day","id":"OG001","title":"Placebo"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Daily from date of randomization until post-op day 2 or date of discharge, whichever comes first.","title":"Change in Daily Narcotic Consumption","type":"PRIMARY","unitOfMeasure":"mg/hour"}